Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1994-8-11
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0025-729X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
161
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
174
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:8028551-Antihypertensive Agents,
pubmed-meshheading:8028551-Australia,
pubmed-meshheading:8028551-Drug Prescriptions,
pubmed-meshheading:8028551-Humans,
pubmed-meshheading:8028551-Insurance, Pharmaceutical Services,
pubmed-meshheading:8028551-Insurance Benefits,
pubmed-meshheading:8028551-Physician's Practice Patterns
|
pubmed:year |
1994
|
pubmed:articleTitle |
Pharmaceutical Benefits Scheme.
|
pubmed:publicationType |
Letter,
Comment
|